Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial

Authors

Sarika Deodhar (ORCID: https://orcid.org/0000-0002-4010-8505)
Lally Mekokishvili
Steven R. Feldman (ORCID: https://orcid.org/0000-0002-0090-6289)
Gursharan Singh (ORCID: https://orcid.org/0000-0003-2416-1266)
Subramanian Loganathan (ORCID: https://orcid.org/0000-0001-7186-0049)
Grażyna Pulka
Elena Wolff‐Holz (ORCID: https://orcid.org/0000-0002-8129-7381)
Adam Reich (ORCID: https://orcid.org/0000-0002-5573-1754)
Airi Põder
Sandeep N. Athalye
Ashwani Marwah
Jacek Cezary Szepietowski (ORCID: https://orcid.org/0000-0003-0766-6342)
Kuldeep Kumar
N I Tsiskarishvili
Inese Svarca

Institutions

Wrocław University of Science and Technology (PL)
Institute of the Estonian Language (EE)
Serviço Nacional de Aprendizagem Industrial (BR)
Vilnius University (LT)
Dynetics (United States) (US)
Centrum Medyczne iMed24 (PL)
Institute of Physical Energetics (LV)
Petre Shotadze Tbilisi Medical Academy (GE)
Biocon (India) (IN)
Georgian American University (GE)
Indiana University School of Medicine
Wake Forest University (US)
AGH University of Krakow (PL)
University of Rzeszów (PL)

Publication Details

Journal: Expert Opinion on Biological Therapy
Published: 2025-10-03
DOI: https://doi.org/10.1080/14712598.2025.2576506
Primary Topic: Biosimilars and Bioanalytical Methods
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial

Sarika Deodhar, Lally Mekokishvili, Steven R. Feldman, Gursharan Singh et al.

Oct 3, 2025

Expert Opinion on Biological Therapy

Biosimilars and Bioanalytical Methods

article

Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial

Sarika Deodhar, Lally Mekokishvili, Steven R. Feldman, Gursharan Singh, Subramanian Loganathan, Grażyna Pulka, Elena Wolff‐Holz, Adam Reich, Airi Põder, Sandeep N. Athalye, Ashwani Marwah, Jacek Cezary Szepietowski, Kuldeep Kumar, N I Tsiskarishvili, Inese Svarca

October 3, 2025article en

Abstract

No abstract available for this paper.

Expert Opinion on Biological TherapyVol. 25(10)

Wrocław University of Science and Technology (PL), Institute of the Estonian Language (EE), Serviço Nacional de Aprendizagem Industrial (BR), Vilnius University (LT), Dynetics (United States) (US), Centrum Medyczne iMed24 (PL), Institute of Physical Energetics (LV), Petre Shotadze Tbilisi Medical Academy (GE), Biocon (India) (IN), Georgian American University (GE), Indiana University School of Medicine, Wake Forest University (US), AGH University of Krakow (PL), University of Rzeszów (PL)

Openalex Percentile: Top 69%

Biosimilars and Bioanalytical Methods

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.